Dow Jones Stock Market Today – Cancer-Focused Werewolf Therapeutics Files for IPO
By Josh Beckerman
Werewolf Therapeutics Inc., which is developing cancer drugs using its Predator protein engineering technology, filed for an initial public offering.
The Cambridge, Mass., company has applied for a Nasdaq Global Market listing under symbol HOWL.
Werewolf said in January that it completed its $72 million Series B financing, led by RA Capital Management. According to the filing, RA Capital has a 11.25% stake. MPM Capital owns 20.75%, and an oncology fund that MPM raised in partnership with UBS Group AG holds 11.56%.
In February, Werewolf named Tim Trost chief financial officer.
Write to Josh Beckerman at josh.beckerman@Fintech Zoom.com
(END) Dow Jones Newswires
April 08, 2021 18:10 ET (22:10 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Market news on Fintech Zoom.